COMMUNIQUÉS West-GlobeNewswire

Cytori to Webcast Fourth Quarter Financial Results on March 8th

22/02/2018 - 22:15

SAN DIEGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX ) will provide a live webcast of its fourth quarter financial results and business update on Thursday, March 8, 2018 at 5:30 PM [...]

BioTelemetry, Inc. Reports Fourth Quarter 2017 Financial Results

22/02/2018 - 22:05

Company Delivers Record Revenue and Adjusted EBITDA Exceeds Expectations MALVERN, Pa., Feb. 22, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ), the leading mobile and wireless medical technology company [...]

Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2017 Financial Results

22/02/2018 - 22:05

MENLO PARK, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) will announce its financial results for the fourth quarter and year ended December 31, 2017, on Friday, March 16, 2018, after the [...]

Pernix Therapeutics to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 8

22/02/2018 - 22:05

MORRISTOWN, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, announced today that the Company will report financial results for the fourth [...]

Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial

22/02/2018 - 22:05

MENLO PARK, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, [...]

CytomX Therapeutics to Announce Full-Year 2017 Financial Results and Host Operational Update Webcast Conference Call

22/02/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a clinical-stage biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of [...]

Tivity Health Reports Fourth-Quarter 2017 Diluted EPS of $0.20 and Adjusted Diluted EPS of $0.41

22/02/2018 - 22:05

REVENUES INCREASE 11.5% TO $139 MILLION ANNOUNCES FINANCIAL GUIDANCE FOR 2018 NASHVILLE, Tenn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY ) today announced financial results for the fourth [...]

Galapagos delivered in 2017

22/02/2018 - 22:02

Key 2017 results: Expansion of filgotinib franchise: Start of 8 new disease area trials Opt-in to co-promote in Europe Second and third platform successes: Halt of disease progression in FLORA trial with GLPG1690 in IPF [...]

OncoMed Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights on March 8th, 2018

22/02/2018 - 22:02

REDWOOD CITY, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq: OMED ), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]

Dermira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

22/02/2018 - 22:01

Olumacostat glasaretil topline Phase 3 data expected Q1 2018 FDA decision on glycopyrronium tosylate New Drug Application expected by June 30, 2018 Lebrikizumab Phase 2b study enrolling patients and data expected H1 [...]

Optinose names Sandra L. Helton as Director and Chairperson of the Company’s Audit Committee

22/02/2018 - 22:01

YARDLEY, Pa., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced its Board of [...]

Endocyte Announces Fourth Quarter and Full Year 2017 Earnings Conference Call

22/02/2018 - 22:01

West Lafayette, Ind., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ: ECYT ) announced today that the company will host a conference call on Monday, Feb. 26th, at 8:30 a.m. EST to discuss its fourth quarter [...]

Nuvectra™ to Report Fourth Quarter and Full Year 2017 Financial Results on March 6, 2018

22/02/2018 - 22:01

PLANO, Texas, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that it will release its financial results for the fourth quarter and full [...]

Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2017

22/02/2018 - 22:01

EMERYVILLE, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today reported recent achievements and financial results for the fourth quarter and full-year ended December 31, 2017. “ [...]

Tabula Rasa HealthCare CEO Presents at IBC Innovation Day

22/02/2018 - 20:43

MOORESTOWN, NJ, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ: TRHC ) Chairman and CEO Calvin H. Knowlton, PhD, spoke at Independence Blue Cross (IBC) Innovation Day 2018 at the [...]

New Published Study Reports Cardiosphere-Derived Cells Improved Skeletal and Cardiac Muscle Function in Mouse Model of Duchenne Muscular Dystrophy

22/02/2018 - 19:23

LOS ANGELES, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced the online publication in Stem Cell Reports of a new study by researchers at the Smidt Heart Institute at Cedars-Sinai [...]

Interpace Diagnostics’ CEO Interviewed on The RedChip Money Report

22/02/2018 - 19:00

PARSIPPANY, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Core Mobility Solutions Launches the LifeGlider Personal Mobility Device

22/02/2018 - 18:30

SAN JOSE, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Core Mobility Solutions, a new mobility device manufacturer, today announced the first commercial launch of the LifeGlider™ at the American Physical Therapy [...]

Tetra Bio-Pharma Announces the Completion of GrowPros Transaction

22/02/2018 - 18:11

OTTAWA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) (TSX-V: TBP ) (OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce the [...]